Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
JCO Precision Oncology is Scopus-indexed (Q1, CiteScore 6.2), WoS SCIE. Published by Lippincott Williams and Wilkins.
Checked against the index lists dated .
ISSN 2473-4284Verify ISSN ↗
Publisher: Lippincott Williams and Wilkins
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 104 / 428 | 75th | Q1 |
| Cancer Research | 92 / 233 | 60th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2017–present, best quartile Q1, CiteScore 6.2.
JCO Precision Oncology is Q1 in Oncology (rank 104 of 428) and Q2 in Cancer Research (rank 92 of 233), by CiteScore 2025.
JCO Precision Oncology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.2, which places it in quartile Q1 at the 75th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.082, quartile Q1, with an H-index of 65.
JCO Precision Oncology is published by Lippincott Williams and Wilkins. Its ISSN is 2473-4284.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
JCO Precision Oncology has an h-index of 75 and a 2-year mean of 3.31 citations per paper (OpenAlex). Its Scopus CiteScore is 6.2, quartile Q1. On 2-year citations it ranks #97 of 424 Scopus journals in Oncology.
JCO Precision Oncology published 313 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from United States (49%), China (9%) and Germany (5.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.